Free Trial

Atomera's (ATOM) "Sell (E+)" Rating Reiterated at Weiss Ratings

Atomera logo with Computer and Technology background

Key Points

  • Weiss Ratings has reaffirmed a "sell (E+)" rating for Atomera (ATOM), indicating continued concerns about the company's stock performance.
  • Atomera reported a quarterly earnings loss of ($0.17) per share, missing analysts' estimates, and recorded a negative net margin of 15,555.37%.
  • Institutional investors currently hold 30.79% of Atomera's stock, with several hedge funds recently acquiring new positions in the company.
  • MarketBeat previews the top five stocks to own by November 1st.

Atomera (NASDAQ:ATOM - Get Free Report)'s stock had its "sell (e+)" rating reaffirmed by investment analysts at Weiss Ratings in a research report issued on Friday,Weiss Ratings reports.

Atomera Stock Performance

Atomera stock traded down $0.08 during mid-day trading on Friday, reaching $3.15. The company's stock had a trading volume of 772,195 shares, compared to its average volume of 593,790. Atomera has a 12-month low of $2.48 and a 12-month high of $17.55. The company has a market capitalization of $99.16 million, a P/E ratio of -4.70 and a beta of 1.13. The firm's fifty day moving average price is $3.85 and its two-hundred day moving average price is $4.71.

Atomera (NASDAQ:ATOM - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The technology company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.03). Atomera had a negative net margin of 15,555.37% and a negative return on equity of 90.84%. The business had revenue of $0.00 million during the quarter.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Police & Firemen s Retirement System of New Jersey purchased a new position in Atomera in the 2nd quarter valued at approximately $35,000. SCS Capital Management LLC purchased a new position in Atomera in the 1st quarter valued at approximately $40,000. Chicago Partners Investment Group LLC purchased a new position in Atomera in the 1st quarter valued at approximately $42,000. Gleason Group Inc. purchased a new position in Atomera in the 2nd quarter valued at approximately $53,000. Finally, The Manufacturers Life Insurance Company purchased a new position in Atomera in the 2nd quarter valued at approximately $53,000. 30.79% of the stock is currently owned by hedge funds and other institutional investors.

About Atomera

(Get Free Report)

Atomera Incorporated engages in the developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry in North America and the Asia Pacific. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Atomera Right Now?

Before you consider Atomera, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atomera wasn't on the list.

While Atomera currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.